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In recent years we have witnessed a major interest in the study of the role of mitochondria, not
only as ATP producers through oxidative phosphorylation but also as regulators of intracellular
Ca2 homeostasis and endogenous producers of reactive oxygen species (ROS). Interestingly, the
mitochondria have been also implicated as central executioners of cell death. Increased
mitochondrial Ca2 overload as a result of excitotoxicity has been associated with the generation
of superoxide and may induce the release of proapoptotic mitochondrial proteins, proceeding
through DNA fragmentation/condensation and culminating in cell demise by apoptosis and/or
necrosis. In addition, these processes have been implicated in the pathogenesis of many neu-
rodegenerative diseases, which share several features of cell death: selective brain areas undergo
neurodegeneration, involving mitochondrial dysfunction (mitochondrial complexes are affected),
loss of intracellular Ca2 homeostasis, excitotoxicity, and the extracellular or intracellular accu-
mulation of insoluble protein aggregates in the brain.
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Mitochondrial dysfunction associated with the loss
of Ca2 homeostasis and enhanced cellular oxidative
stress have long been recognized to play a major role in
cell damage associated with excitotoxicity (1), a process
resulting from the overstimulation of glutamate recep-
tors. Under this perspective, the stimulation of ionotropic
glutamate receptors responsible for a major Ca2 entry,
in particular, the N-methyl-D-aspartate (NMDA) receptors
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and the -amino-3-hydroxy-5-methyl-4-isoxazolepropio-
nate (AMPA) receptors lacking the GluR2 subunit, are
highly implicated in the process of neuronal death
(e.g., [2–5]). Energy depletion and increased oxidative
damage to several synaptic proteins may result in loss
of local Ca2 homeostasis, and, in consequence, synap-
tic degeneration occurs. Calcium is known to activate
several intracellular enzymes, such as phospholipase A2,
nitric oxide synthase, xanthine dehydrogenase, cal-
cineurin, and endonucleases, many of which can elicit
the generation of endogenous ROS. Moreover, when
taken up by the mitochondria, Ca2 can physiologically
increase ATP generation by activating matrix dehydro-
genases (6). However, an increase in mitochondrial Ca2
can also promote ROS generation (7).
Neurons are highly dependent on glucose for ATP
generation necessary for many biochemical processes and
produce ROS as by-products of the oxidative phospho-
rylation within the mitochondria. Inevitably, if the amount
of ROS produced unbalances the few antioxidants, oxida-
tive stress occurs, followed by neuronal damage. The
CNS is particularly susceptible to ROS-induced damage
(reviewed in [8]) because (i) it has a high consumption
of oxygen; (ii) it contains high levels of membrane
polyunsaturated fatty acids susceptible to free radical
attack; (iii) it is relatively deficient in oxidative defenses
(poor catalase activity and moderate superoxide dismu-
tase, SOD, and glutathione peroxidase activities); and (iv)
a high content in iron and ascorbate can be found in some
regions of the CNS, enabling the generation of more ROS
through the Fenton/Haber Weiss reaction. Moreover,
ROS have been demonstrated to mediate neuronal death
in several neurodegenerative diseases such as Parkinson’s
(PD), Alzheimer’s (AD), amyotrophic lateral sclerosis
(ALS), and Huntington’s disease (HD).
Intracellular Ca2 overload associated with excito-
toxicity has long been described to induce both apoptosis
and necrosis (9), although the exact distinction between
these two processes is not always clear. Apoptosis is
a highly regulated cellular suicide program with distinct
morphological features, required for embryonic develop-
ment, for maintenance of cellular homeostasis, and
occurring in many degenerative diseases. The biochem-
ical machinery involved in apoptosis is conserved from
Caenorhabditis elegans and Drosophila to mammals. In
addition, many proapoptotic stimuli converge on mito-
chondria, inducing the increase in permeabilization of the
outer mitochondrial membrane. Thus a key event in
apoptosis is the release of cytochrome c to the cytosol,
although the release of other mitochondrial factors also
seems to help regulate the apoptotic machinery through
a process dependent on or independent (e.g., the apop-
tosis-inducing factor or AIF) of caspases activation.
These processes culminate with DNA fragmentation and
condensation. The slow, cascade-dependent apoptotic
cell death process has been implicated to occur in sev-
eral neurodegenerative diseases (10), although its
involvement is still not clear in all these disorders, of
which one of the most controversial is HD.
Here we summarize some of the most relevant
hallmarks of the cell death process, with the main
emphasis on apoptosis, along with recent advances in
the mechanisms involved. The analysis of the role of
mitochondria in the regulation of Ca2 homeostasis and
in ROS generation during excitotoxicity and general cell
demise also will be discussed. Finally, the relevance and
involvement of some of the basic features of neuronal
demise in three neurodegenerative diseases, PD, AD,
and HD, will be addressed.
DISCUSSION
Involvement of the Mitochondria in the Apoptotic
Machinery
Death Receptor or Mitochondrial Apoptotic Path-
ways. Two main apoptotic pathways have been identi-
fied: the pathway involving the activation of death
receptors and the mitochondrial pathway, both involving
the activation of a caspase cascade (Fig. 1).
The death signals tumor necrosis factor (TNF) or Fas
ligand interact with the death receptors at the plasma
membrane, resulting in the recruitment of adaptor mole-
cules such as the Fas-associated protein with death domain
(FADD), which are responsible for activating caspase-8
through the interaction of the death effector domains.
Activated caspase-8 can directly activate caspases-3 and
-7 (effector caspases), but it can also cleave Bid, a BH3-
only member of the B-cell leukemia/lymphoma 2 (Bcl-2)
family of proteins. The cleaved C-terminal Bid (truncated
Bid or tBid) translocates to the mitochondria and induces
the release of (holo)cytochrome c (Fig. 1), linking the
death receptor pathway with the mitochondrial pathway
(11). Interaction of tBid with the mitochondria does
not seem to require the activation of the permeability
transition pore (PTP) or the proapoptotic protein Bcl-2–
associated X protein (Bax), although tBid and Bax can
function synergistically (12). In addition, Bid-induced
cytochrome c release can be antagonized by Bcl-2, a cell
death repressor protein (11).
Many death stimuli (e.g., growth factor deprivation,
ionizing radiation, and several chemical agents) activate
the mitochondrial pathway by inducing the release of
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Fig. 1. Schematic overview of the death receptor and mitochondrial
apoptotic pathways. External ligands interact with death receptors,
activating the initiator caspase-8, which can cleave Bid. tBid translo-
cates to the mitochondria and induces the release of cytochrome c
(cyt c) to the cytosol, linking the death receptor pathway with the
mitochondrial pathway. Activation of caspase-2 may also induce Bid
cleavage and signal the mitochondria to release cyt c, implicating the
mitochondria as amplifiers of the caspase cascade. Within the cytosol,
cyt c forms the apoptosome (in the presence Apaf-1, dATP and pro-
caspase-9) activating caspase-9. The effector caspases -3 and -7, which
can be activated by caspases -8 or -9, are required for the activity of
the endonuclease DFF40/CAD, responsible for genomic DNA frag-
mentation. In addition, Smac/Diablo (released from the mitochondria)
binds to IAPs, potentiating caspase activation. AIF is also released to
the cytosol and translocates to the nucleus, inducing the fragmentation
of DNA and killing the cells in a caspase-independent manner.
(holo)cytochrome c. Within the cytosol, cytochrome c
initiates the formation of the apoptosome, a multimeric
complex, after binding to the apoptotic protease activ-
ating factor-1 (Apaf-1) in the presence of deoxyATP.
This complex is responsible for activating caspase-9
(Fig. 1). Curiously, the apocytochrome c (lacking the
heme) still binds Apaf-1, but blocks caspase-9 activation
and Bax-induced apoptosis (13). Then the initiator cas-
pase-9 activates the downstream caspases -3, -6, and -7.
Caspase-3 (and also caspase-7) is required for the cleav-
age of the 45-kD subunit of the DNA fragmentation
factor (DFF) or DFF45 (ICAD or inhibitor of caspase-
activated DNase is the mouse homologue), releasing the
DFF40 (CAD is the mouse homologue) with nuclease
activity, responsible for DNA fragmentation during
apoptosis (14) (Fig. 1).
Apart from cytochrome c, the increase in perme-
ability of the outer mitochondrial membrane may also
mediate the release of the apoptosis-inducing factor (AIF)
(15), a phylogenetically old flavoprotein that can stably
bind FAD ([16], for review). After an apoptotic insult,
this protein is released to the cytosol and translocates to
the nucleus, where it binds to the DNA and induces its
fragmentation, independently of the activity of caspases
(Fig. 1). A similar function was associated to endonu-
clease G, a mitochondria-specific nuclease (present in the
intermembrane space) that translocates to the nucleus and
cleaves chromatin DNA during apoptosis, killing the cells
in a caspase-independent manner (17).
Similar to cytochrome c, the second mitochondrial
activator of caspases (Smac)/direct IAP binding protein
with low pI (Diablo), a protein that binds to inhibitor of
apoptosis proteins (IAPs), is released from the mito-
chondria and potentiates apoptosis by relieving IAP
inhibition of caspases (Fig. 1), as identified by Verhagen
et al. (18) and Du et al. (19). Smac/Diablo, like the serine
protease Omi/Htr2A (also released from the mitochon-
dria), interacts with several IAPs and mediates the acti-
vation of the initiator caspase-9 and the effector caspases
-3, -6, and -7. Interestingly, release of Smac can occur
before or in parallel with cytochrome c, in a process
modulated by the antiapoptotic proteins Bcl-2 and
Bcl-XL upon apoptosis induced by the TNF-related apop-
tosis-inducing ligand (TRAIL) (20). In cells exposed to
staurosporine (STS), the time required for Smac/Diablo
release was shown to be about four times longer than that
required for cytochrome c, suggesting that distinct path-
ways for exit from the mitochondria could be used by
these proteins (21). STS is a protein kinase C inhibitor
that induces apoptosis in a variety of cells (22–25),
although the exact mechanism is still not clear.
The ubiquitous caspase-2 was one of the first cas-
pases to be identified; however, the mechanisms
involved in caspase-2 activation and related Bcl-2 pro-
tection are not completely understood yet. Recent
important contributions to this field were made by
Lassus et al. (26). They found that caspase-2 is required
for translocation of Bax to the mitochondria and release
of cytochrome c and Smac/Diablo. Other authors have
also reported that caspase-2 induces the release of AIF
and that Bid may also be involved (reviewed in [27]).
These, together with data referring that caspase-2 in the
nucleus signaled the mitochondria to release cytochrome
c, implicated the mitochondria as amplifiers rather than
initiators of caspase activity (26,27).
An interesting observation is that increased mito-
chondrial inner membrane permeability, defined by the
formation of the PTP, has been suggested to be involved
not only in apoptotic but also in necrotic cell death, and
in autophagy, a less studied form of cell death that may
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Fig. 2. Regulation of apoptosis by Bad phosphorylation/dephosphory-
lation. In the presence of an apoptotic stimuli (e.g., Ca2-calmodulin),
calcineurin dephosphorylates Bad, which is translocated to the mito-
chondria, where it interacts with Bcl-2 or Bcl-XL. Under these condi-
tions, release of cytochrome c (cyt c) to the cytosol occurs, triggering
the apoptotic machinery through the activation of the caspase cascade.
Activation of the receptors for neurotrophins (Trk receptors) activates
the PI3K/Akt or MAPK signaling pathways, responsible for phosphory-
lating Bad. Phosphorylated Bad at Ser112 and Ser136 is sequestrated
by the cytosolic protein 14-3-3, avoiding its translocation to the
mitochondria.
be implicated in removing damaged mitochondria (28).
Thus the occurrence of necrosis or apoptosis-type of cell
death may depend upon the intracellular levels of ATP,
as accepted some years ago: if the ATP levels fall,
plasma membrane rupture occurs; if ATP levels are
maintained, the caspase-dependent apoptotic machinery
can proceed. In serum deprived PC12 cells, with rec-
ognized apoptotic features, Uchiyama (29) has described
the occurrence of autophagy, regulated by lysosomal
proteinases, cathepsins B and D, in the early stages of
apoptosis, before the appearance of nuclear changes.
Moreover, apoptosis was prevented in the presence of
an autophagy inhibitor (29).
Bcl-2 Related Proteins: Bax, Bad, and Bcl-2. The
Bcl-2 family members are key players in the apoptotic
process. Some members of this family promote cell
survival (Bcl-2 or Bcl-XL), whereas others are proapop-
totic (Bax, Bak, Bad, Bik, and Bim).
The proapoptotic Bax was previously reported to
mediate the release of cytochrome c through the opening
of the PTP, in a process regulated by cyclosporin A (30).
However, Bax was also demonstrated to trigger
cytochrome c release from isolated mitochondria inde-
pendently of the Ca2-inducible, cyclosporin A-dependent
PTP (31). More recently, Bax was shown to be translo-
cated from the cytosol to the mitochondria forming homo-
oligomers responsible for cytochrome c release (32).
Activation of the receptors for neurotrophins plays
an important role in regulating the apoptotic activity of
the BH3-only proteins. One known example is the regu-
lation of the Bcl-2–associated death protein (Bad). Phos-
phorylation of Bad at Ser112 and Ser136, namely by the
phosphatidylinositol-3-kinase (PI3K)/Akt (protein kinase
B) signaling pathway, mediates its sequestering by the
cytosolic protein 14-3-3, avoiding its heterodimerization
with Bcl-2 and Bcl-XL at the mitochondrial membrane
(Fig. 2). In contrast, in the presence of an apoptotic
stimuli (e.g., Ca2-calmodulin induced activation of
calcineurin or protein phosphatase 2B), dephosphorylated
Bad is released from the 14-3-3 anchor and is translo-
cated to the mitochondria (Fig. 2), free to execute its
proapoptotic activity. By binding to Bcl-2 or Bcl-XL, the
antiapoptotic function of these proteins is no longer
exerted, allowing the release of cytochrome c to the
cytosol. Seizure-induced hippocampal neuronal death was
recently associated with the activation of Bad cell death
pathway (33). Moreover, in traumatic spinal cord injury,
the apoptotic cascade involving caspase-3 activation was
shown to depend upon calcineurin-mediated Bad dephos-
phorylation (34). In recent studies, calcineurin was also
implicated in 3-nitropropionic acid–induced cytochrome
c release and caspase-3 activation in cultured cortical and
striatal neurons (Almeida, Brito, Oliveira, and Rego,
unpublished results).
Bcl-2, known as ced-9 in C. elegans, is one of the
antiapoptotic proteins first recognized to prevent the
release of mitochondrial cytochrome c (35). Bcl-2 fam-
ily members seem to be associated with the outer mito-
chondrial membrane, the endoplasmic reticulum (ER),
and the nuclear envelope. Interestingly, expression of
Bcl-2 targeted to the mitochondria was reported to
induce apoptosis, whereas expression of this protein
targeted to the ER was shown to be protective against
Bax-induced cell death (36). Bcl-2 protection of Bax-
induced apoptosis seems to be related with Bax remain-
ing monomeric, although it may not depend on a
physical interaction between the two proteins (32). In
addition, Bcl-2 has been shown to inhibit intracellular
formation of free radicals (37), shifting the redox poten-
tial of cells toward reduction (38), and increase the
capacity of mitochondria to accumulate Ca2 (39). Bcl-2
can be modulated by dimerization, for example with
Bax, and by phosphorylation (by protein kinase C),
although the role of Bcl-2 phosphorylation as a regulator
of its antiapoptotic activity is still controversial.
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Loss of Mitochondrial Potential and Apoptotic Cell
Death. Opening of the PTP (to release cytochrome c)
is activated by Ca2, ROS, and a decrease in mito-
chondrial membrane potential (m). Nevertheless,
mitochondrial depolarization is not always associated
with the release of cytochrome c.
In PC6 cells, STS-induced apoptosis was associ-
ated with a concomitant release of cytochrome c (as a
green-fluorescent–protein construct) and collapse of
m (23). However, other authors have found that the
release of cytochrome c into the cytosol occurs inde-
pendently of mitochondrial depolarization during STS-
induced apoptosis (22,40). In GT1–7 cells, we have
previously observed that some mitochondria could lose
their cytochrome c during STS-induced apoptosis by a
mechanism independent of a collapse in m (25). By
using oligomycin, we demonstrated that the cells main-
tained the m following cytochrome c release by ATP
hydrolysis. In addition, we showed that STS decreased
state-3 respiration, implicating the inhibition of electron
transport chain and a consequent compromise in respi-
ratory function, which could be in the basis for ATP
hydrolysis (25). Similar to Zhu et al. (39), we have
shown that overexpression of Bcl-2 prevented a decrease
in mitochondrial potential elicited by STS (25).
Bid and Bad, two BH3-only proteins, but not Bax
or Bak, were also shown to induce cytochrome c release
without changes in m or the opening of the PTP and
without interacting with the voltage-dependent anion
channel (VDAC) (41).
The Mitochondria and the Endoplasmic Reticulum
Crosstalk. Not only do mitochondria have a relevant role
in apoptotic cell death, but other organelles, such as the
ER, seem to be quite sensitive to perturbations in ion
homeostasis, oxidative stress, or metabolic perturbations
in the cell. It has long been recognized that mitochondria
are capable of sequestering Ca2 released from inositol
trisphosphate–stimulated neighboring ER (42). Interest-
ingly, some of the Ca2 taken up by the mitochondria
seems to be recycled back to refill the ER, as determined
by using the “cameleon” indicators targeted to the
cytosol, ER lumen, and mitochondrial matrix (43).
Recently, it was demonstrated that the VDAC in the outer
mitochondria membrane may enhance the transfer of
Ca2 from the ER to the inner mitochondria membrane
and increase the sensitivity to apoptotic cell death induced
by ceramide (44), involved as a second messenger in the
sphingomyelin cycle. The ER stress involves the alter-
ation of protein folding processes or the accumulation of
malformed proteins. Caspase-12, an ER resident caspase,
is activated during ER stress. Recent data suggest that
neuronal apoptosis, determined by caspase-12 activation
and nuclei fragmentation, can be induced by ER stress in
the presence of brefeldin A, an inhibitor of ER to Golgi
protein transportation, through the activation of the NF-
kB pathway (45). In damaged neurons, the increased
expression of the resident Golgi protein axotomy-induced
glycosylated/Golgi complex protein 1 (AIGP1) by ER
stress inducers may contribute to interorganelle signaling
during apoptotic neuronal death (46). ER stress–mediated
cell death was also demonstrated to require translocation
of caspase-7 to the ER surface, necessary for the cleavage
of the prodomain of caspase-12; in addition, caspase-12
was reported to move into the cytoplasm upon a pro-
longed ER stress, interacting with caspase-9 (47), highly
suggesting the coupling between an “ER-apoptotic
pathway” with the known mitochondrial pathway.
In fact, an intricate interorganelle cross-talk was
previously suggested by Ferri and Kroemer (48), who
reviewed the participation of distinct organelles, namely
the nuclei, lisosomes, ER, and Golgi, in the release of




NMDA Excitotoxicity. Exposure of neurons to glu-
tamate was previously demonstrated to result in mito-
chondrial depolarization associated with increased Ca2
uptake into the mitochondria (e.g., 9,49–51).
Activation of NMDA receptors was reported to
induce faster mitochondrial Ca2 uptake and in a more
tightly coupled way, compared to kainate or KC1. This
observation suggested a privileged access to mitochondria
of Ca2 entering through NMDA receptors, which could
be accounted for by the possibility that mitochondria are
in closer proximity to NMDA receptors than other routes
of Ca2 entry (49). In previous work, we reported that
NMDA receptor–dependent transient mitochondrial Ca2
loading could initiate oxidative damage (e.g., affecting
plasma membrane Ca2 extrusion pathways, namely the
Ca2-ATPase) and/or inhibit mitochondrial respiration,
two factors suggested to precipitate delayed Ca2 dereg-
ulation, a failure of the cell to maintain a low cytoplas-
mic free calcium concentration (51). In cultured retinal
neurons, we have also observed a decrease in oxygen con-
sumption upon glutamate exposure, coincident with the
inhibition (by about 20%) in the activity of mitochondrial
complexes I, II/III, and IV (52). Curiously, during con-
tinuous activation of the NMDA receptors, mitochondria
depolarization occurred concomitantly with the delayed
Ca2 deregulation (51), which seems to precede the
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subsequent necrotic death of the cell (2). In addition, in
cells stimulated with glutamate and glycine, the mito-
chondria continued to generate ATP (53). Once started,
the NMDA receptor–induced delayed, secondary Ca2 rise
was shown to be irreversible in cultured cerebellar gran-
ule cells, as determined upon exposure to antagonists of
NMDA or non-NMDA glutamate receptors, Ca2 channel
blockers, or even in the presence of inhibitors of the
PTP (53). Nevertheless, in striatal neurons Alano et al.
(54) have recently shown that exposure to N-methyl-
valine-4-cyclosporin, a blocker of the PTP, prevented the
secondary cytosolic Ca2 rise induced by NMDA recep-
tor activation.
The occurrence of apoptosis upon NMDA excito-
toxicity has been controversial. During excitotoxicity,
the release of mitochondrial cytochrome c associated
with a delayed mitochondrial depolarization and pro-
duction of ROS were documented (55,56). Previous
reports have also showed that caspase-3, in particular,
plays a major role in NMDA excitotoxicity (57). More-
over, AIF translocation was observed upon the stimula-
tion of the NMDA receptors in a process requiring the
activation of poly(ADP-ribose)polymerase (PARP) and
the consequent depletion of NAD (58), although the
mechanisms involved are still not completely clear.
AMPA Excitotoxicity. Both delayed Ca2 deregu-
lation and mitochondrial depolarization were found after
kainate stimulation in cerebellar granule cells (59).
Kainate is known to activate nondesensitizing AMPA
receptors and mediate a large increase in cytosolic Na,
suggesting an important role in cell swelling (60). How-
ever, we found that, in contrast with NMDA receptor
activation, the mitochondria were not highly loaded with
Ca2 upon kainate stimulation in cerebellar granule cells
(59). Nevertheless, mitochondrial Ca2 loading upon
kainate exposure was observed, for example, in spinal
motor neurons (4). Inhibition of ATP synthase with
oligomycin was shown to protect the cells against
kainate-induced delayed Ca2 deregulation, inducing a
slow mitochondrial depolarization (59). These results
indicated that m could be maintained by ATP
synthase reversal, presumably through the hydrolysis of
glycolytic ATP, highly suggesting the failure of
oxidative phosphorylation.
Both necrotic and apoptotic types of cell death have
been attributed to the neurotoxic effects of AMPA/kainate
receptor stimulation, as reported in cerebellar granule
cells (3) or cortical neurons (61). Recently, we have
demonstrated that a brief stimulation of AMPA receptors
under nondesensitizing conditions induces neuronal death
by necrosis and apoptosis in hippocampal cultures, as
determined by the loss of cell viability, the release of
cytochrome c, the activation of caspases -1 and -3, and
DNA condensation/fragmentation, without significant
changes in intracellular ATP/ADP levels (62). In add-
ition, kainate excitotoxicity was shown to be related to
the induction of Bax, the release of cytochrome c, and
the activation of several caspases in hippocampal slice
cultures, together with a p53-dependent neuronal death
(5). Importantly, secondary activation of NMDA recep-
tors, stimulated by depolarization-induced removal of
Mg2 blockade, can occur after AMPA-mediated cytoso-
lic Na loading (63), giving rise to a large percentage of
neurons entering into necrosis.
The Deleterious Power of ROS in Excitotoxicity
and Apoptosis
The superoxide anion (O2 ) is generated in a con-
stant manner by the mitochondria. The semiquinone
form of coenzyme Q is an important electron leakage
site in the inner mitochondrial membrane (64). Thus,
increased Ca2 uptake by the mitochondria was
reported to stimulate oxygen radical production from
the reduced form of coenzyme Q (7). In more recent
studies, Maciel et al. (65) have determined that Ca2-
induced opening of the PTP in brain mitochondria
potentiates the formation of mitochondrial ROS and
lipid peroxidation by depleting the levels of NAD(P)H.
Production of O2 has been also associated with
increased NMDA or kainate excitotoxicity, which can
lead to the disruption of mitochondrial energy
production and cell death, as evaluated by the inactiv-
ation of aconitase, a key enzyme in the TCA cycle
(66). An enhancement in O2 formation may also be
in the basis for cytochrome c release, as reported by
Atlante et al. (55) in cerebellar granule neurons under-
going glutamate-induced excitotoxicity. Otherwise,
O2 generation may occur secondary to cytochrome c
release, as observed upon NMDA-neurotoxicity (56).
In addition, activation of AMPA receptors was previ-
ously shown to enhance the production of mitochon-
drial O2 (4,67). In recent studies, we have observed
a moderate increase in O2 , without a detectable
generation of intracellular peroxides after a brief
desensitization of AMPA receptors in cultured rat hip-
pocampal neurons (62). According to Luetjens et al.
(56), delayed O2 generation during excitotoxicity
occurs secondarily to a defect in mitochondrial elec-
tron transport, downstream of mitochondrial cyto-
chrome c release. Cai and Jones (68) have shown that
O2 is formed from mitochondria isolated from
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that Bcl-2 could protect from O2 by preventing the
release of cytochrome c, explaining the antioxidant
properties (37) of this antiapoptotic protein.
The activity of SOD (Mn-SOD and/or Cu/Zn-SOD)
controls the levels of O2 , producing hydrogen perox-
ide (H2O2). Similarly to O2 , H2O2 is not very reactive,
unless it encounters Fe2 or Cu to form the highly
reactive and short-lived (about 109 s) hydroxyl radical
(HO•) by the Fenton-Haber Weiss reaction. Importantly,
an increased expression of Cu/Zn-SOD was shown to
reduce oxidative stress and attenuate apoptotic cell death
by decreasing mitochondrial cytochrome c and
Smac/Diablo release and the activation of caspases (69),
in agreement with previous studies showing that SOD
delayed neuronal apoptosis induced by nerve growth
factor deprivation (70). Sublethal exposure to H2O2 was
shown to cause the formation of the PTP, resulting in
mitochondrial membrane depolarization and cytochrome
c release, which could be prevented by cyclosporin A,
a blocker of the PTP (71).
During apoptosis induced by STS, increased intra-
cellular Ca2 concentration and enhanced formation of
ROS have been observed (24,72), suggesting that the cas-
pases could be redox regulated. Using retinal cell cultures,
we determined that STS-mediated apoptotic death
increased the production of intracellular peroxides and
that distinct antioxidants, but not reducing agents, were
able to prevent from caspases activation and DNA frag-
mentation (Gil, Oliveira and Rego unpublished results).
Previously, the antioxidant trolox, a lipophilic analogue
of vitamin E, was shown to protect against apoptosis
induced by H2O2 by preventing DNA fragmentation (73).
Vitamin E or the superoxide dismutase-mimetic MnT-
BAP was shown to reduce apoptosis induced by STS in
cultured rat hippocampal neurons (74). Moreover, STS-
mediated glutathione depletion and apoptotic injury were
shown to be prevented by vitamin E and retinoic acid in
cultured chick embryonic neurons (75).
Features of Cell Death in Three Human
Neurodegenerative Diseases: Parkinson’s,
Alzheimer’s, and Huntington’s Diseases
The pathogenesis of the majority of the neurode-
generative disorders involves a genetic predisposition
together with the activity of environmental (mitochon-
drial) toxins. The accumulation of abnormally folded
proteins, leading to the activation of heat-shock/stress
responses and, particularly, the formation of insoluble
protein aggregates (because the proteins adopt -sheet
structures) in the brain seem to be common features of
several neurodegenerative diseases ([76], for review).


 Thus the amyloid-like fibrillary aggregates may arise in
the intracellular or extracellular milieu in many neu-
rodegenerative diseases. However, the nature of patho-
genic aggregate formation and the exact consequences
of their accumulation are still not clear. Moreover, there
are still some controversies concerning the evidence for
classical apoptosis in many neurodegenerative diseases,
that is, AD, PD, ALS, and HD.
Parkinson’s Disease. PD is characterized by a
selective degeneration of the dopaminergic neurons of
the substantia nigra and the formation of intracellular
fibrillar -synuclein and ubiquitin, two protein com-
ponents of the Lewy bodies. Autosomal recessive
juvenile forms of PD result from mutations in parkin,
a ubiquitin protein ligase, shown to elevate oxidative
stress (increased protein carbonyls and lipid peroxi-
dation) and nitric oxide production upon expression,
sensitizing to cell death processes (77). An apoptotic
type of cell death involving the mitochondria has been
suggested to occur in PD, concomitantly with the
observation of a decrease in the activity of mitochon-
drial complex I, which may result in oxidative stress
and increase the susceptibility of neurons to excito-
toxic death. Alterations in mitochondrial function,
activation of caspases, and cell death with apoptotic
morphology have been described in several models of
PD and in postmortem brains of PD patients. In addi-
tion, the degeneration of dopaminergic neurons cause
a unique form of oxidative stress induced by the oxi-
dation of dopamine, which can produce H2O2, via
monoamine oxidase, or produce a quinone, upon oxi-
dation of its catechol group.
Epidemiological studies have made clear that
exposure to pesticides is associated with an increased
risk of developing PD, suggesting a high relevance of
environmental toxins in PD pathogenesis. The toxins
rotenone and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyri-
dine (MPTP) inhibit mitochondrial complex I,
reproducing most of the features of PD by producing
selective degeneration of dopaminergic neurons of the
substantia nigra. Interestingly, chronic exposure to
rotenone was reported to cause the accumulation and
aggregation of -synuclein and ubiquitin (78,79),
progressive oxidative damage, and caspase-dependent
cell death (79). Moreover, the -synuclein inclusions
disappeared after restoring the normal mitochondrial
metabolism (78). Rotenone-induced apoptosis was also
associated with an increase in the processing of pro-
caspases -12, -9, and -3, suggesting that both mito-
chondria and ER-dependent caspases are activated (80).
-Synuclein also appears to have an antiapoptotic
role, as detected through a reduction in STS-induced
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caspase-3 activation, DNA fragmentation, or p53 expr-
ession (81). However, the natural toxin 6-hydroxy-
dopamine was shown to abolish this -synuclein role,
triggering its aggregation, a pathological hallmark of
PD. Nevertheless, an earlier report indicated that over-
expression of wild-type -synuclein delayed cell death
induced by H2O2 or serum withdrawal, attenuating the
decrease in reduced glutathione, although aggravating
the effects induced by STS (82). Expression of mutant
-synucleins, involved in some cases of familial PD,
was shown to increase cellular oxidative stress, as deter-
mined through the oxidation of DNA, proteins, and
lipids (82).
Alzheimer’s Disease. In AD, processing of amy-
loid precursor protein (APP) by - and -secretases pro-
duces the amyloid -peptide (A) with 40–42 amino
acids, which accumulate extracellularly, forming insol-
uble structures. In fact, A is the prominent component
of senile plaques found in brains of AD patients. More-
over, intracellular neurofibrillary tangles formed by
phosphorylation of tau are also found, although not
restricted to AD. Age is the main risk for AD, charac-
terized by a global cognitive decline. Autosomal domi-
nant familial forms are caused by mutations in APP,
presenilin 1 (PS1), or presenilin 2 (PS2), mainly
associated with the early onset of AD.
A has been implicated in neuronal and vascular
degeneration in brain regions susceptible to plaque
formation, because it can cause toxicity to neurons and
to endothelial cells. In a previous report, Xu et al. (83)
have shown that both A25–35 and A1–40 induced
apoptotic cell death in cerebral endothelial cells, as
evaluated by increased oxidative stress, caspase acti-
vation, mitochondrial dysfunction, and DNA damage.
In fact, A-neurotoxicity has been associated with
almost all cell death processes (apoptosis and necro-
sis), including mitochondrial dysfunction (due to com-
plex IV inhibition) associated with impaired energy
metabolism, increased generation of ROS (including
formation of carbonyl groups, lipid peroxidation, and
nucleic acid oxidation), disruption of Ca2 homeosta-
sis, excitotoxicity, altered synaptic plasticity, apop-
totic features of cell death involving the mitochondria
(e.g., cytochrome c release, and activation of caspases
-2, -9, and -3), ER-stress (e.g., caspase-12 activation),
and DNA fragmentation/condensation, activation of
inflammatory processes, leading to proliferation
of microglia and general loss of cell viability
(e.g., reviewed in [10]). Under this perspective, we
have shown that A exacerbates the Ca2-induced
opening of the PTP in brain mitochondria, without
inducing the PTP per se (84). In addition, we have
demonstrated that a functional mitochondria is
required for A-induced neurotoxicity, as investigated
using 	 and 	0 mitochondrial DNA depleted cells
(85). Interestingly, several antioxidants (vitamin E,
idebenone, and reduced glutathione), melatonin, and
nicotine showed protective effects by maintaining the
mitochondrial membrane potential, improving the
activity of the respiratory complexes and the cellular
energetic levels (85).
APP can be proteolytically cleaved by caspases -6,
-8, and -9, generating a C-terminal peptide (unrelated
with A) that can induce cell death not only in AD but
also in other neurodegenerative disorders. Recently, a
novel protein, the presenilin-associated protein (PSAP),
shown to interact with PS1 C-terminus, was reported to
be a mitochondrial resident protein associated with a
proapoptotic activity through the release of cytochrome
c, caspase-3 activation, DNA fragmentation, and cleav-
age of PARP (86). Importantly, A1–40 neurotoxicity also
requires NMDA excitotoxicity, as determined by the pro-
tective effects of memantine, an uncompetitive NMDA
receptor antagonist, upon A1–40 injection in the hip-
pocampus, an insult causing neuronal degeneration,
pyknotic nuclei, and astrocytic and microglia activation
in this cerebral area (87).
Insulin dysfunction has been suggested to play a role
in AD because diabetes mellitus seems to increase the
risk of AD (88). The insulin receptor was shown to be
expressed in the hippocampus and in the cerebral cortex,
two brain areas affected in AD, but its role in the brain
is still unclear. Although insulin may regulate the phos-
phorylation of tau or interfere with the metabolism of
APP, any beneficial effect of the hormone as a thera-
peutic intervention against AD is still questionable (88).
Nevertheless, insulin has been suggested to play an anti-
apoptotic role by activating NF-kB, increasing the expres-
sion of Mn-SOD in a cell line (89) or by reducing the
activation of caspase-3 through a mechanism dependent
on PI3K/Akt signaling pathway in retinal neurons (90).
Huntington’s Disease. HD is a genetic autosomic
disease characterized by the expansion of CAG repeats
in the gene that codes for huntingtin, a cytoplasmic
protein of unknown function. Because the CAG triplet
codes for glutamine, when mutated, the protein presents
a polyglutamine tract at the N-terminus resulting from
more than 38/39–55 CAG repeats (in adult-onset HD),
while expansion of 70 repeats or more occur in juve-
nile cases, in contrast with normal individuals contain-
ing less than 35 CAG repeats. In fact, expansion of CAG
repeats is the underlying cause of at least nine inherited
human neurodegenerative disorders, including HD and
spinocerebellar ataxias.
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Polyglutamine fragments accumulate as aggregates
in the cytoplasm or nucleus (nuclear inclusions), and
induce neuronal cell death. However, the molecular
mechanism of polyglutamine-induced cell death is still
controversial. HD is characterized by abnormal invol-
untary movements and cognitive impairment, with a
predominant dysfunction in the striatum (particularly
the striatal spiny neurons) and cortex. A decrease in the
activity of mitochondrial complex II has been observed
in the brains of HD patients, and interestingly, systemic
injection of 3-nitropropionic acid was shown to mimic
the pathological hallmarks of HD in several animal
models by inducing a preferential degeneration of the
striatum. Such a lesion exhibited nuclear DNA frag-
mentation and strong expression of the proapoptotic
protein Bax, suggesting the occurrence of apoptotic cell
death at the site of the severe striatal lesion induced by
3-nitropropionic acid (91). This toxin was recently
shown to induce striatal degeneration via activation (by
phosphorylation) of the c-Jun N-terminal kinase, fol-
lowed by its translocation to the nucleus and activation
of the transcription factor c-Jun (92).
Apoptotic features, determined by a redistribution
of cytochrome c and activation of caspase-9, were also
observed in both HD patients and in the R6/2 trans-
genic model of HD at the endstage of the disease, cor-
related with severe neuropathological deficits (93). Both
caspase and calpain cleavage sites were identified in
huntingtin (94), leading to the formation of truncated,
smaller fragments that accumulate in the nucleus,
potentiating huntingtin cytotoxicity. Cleavage by cal-
pains was shown to depend upon the size of the polyg-
lutamine repeat tract (increased length correlated with
increased susceptibility) and occurred independently of
caspase cleavage. Nevertheless, in transgenic mouse
models of HD, no signs of cell death by apoptosis or
necrosis were observed in dying neurons exhibiting
intranuclear inclusions, because organelle structure was
preserved, without evidence of membrane blebbing,
apoptotic bodies, or fragmentation of DNA (95).
In the YAC transgenic mouse model expressing
full-length huntingtin, an increased susceptibility for
NMDA receptor–induced neuronal death, associated
with NR2B-subunits and caspase-3 activation, was
observed upon intrastriatal injection of quinolinic acid
(96), confirming the evidence that implicated the process
of excitotoxicity in HD neuropathology. Interestingly,
mitochondria isolated from lymphoblasts of HD patients
or brain mitochondria obtained from transgenic mice
expressing full-length huntingtin showed a decreased
m and depolarized for lower Ca2 concentrations,
compared with the control (97). This effect could be
accounted for by the identification of N-terminal mutant
huntingtin on neuronal mitochondria, highly suggesting
its direct effect on the organelle.
Normal huntingtin, on the other hand, has been
described to be neuroprotective, by playing an anti-
apoptotic role as a blocker of procaspase-9 processing,
interfering with the apoptosome complex, downstream
of cytochrome c release (98). However, a Ca2-depend-
ent cleavage (by calpains) of wild-type huntingtin under
stressed conditions (e.g., glutamate excitotoxicity or
mitochondrial dysfunction resulting from complex II
inhibition) was reported to reduce the neuroprotective
activity of wild-type huntingtin (99).
CONCLUSION
In recent years the mitochondria have assumed a
great importance by clarifying the link between differ-
ent signaling molecules (e.g., cytosolic Ca2) and the
commitment to cell death. Mitochondria regulate the
death execution phase, marking the point of no return
in necrosis and apoptosis. Therefore we need to know
more about the less clarified upstream mitochondrial
pathways that can be involved in the initiation phase
of human neurodegenerative disorders. This can be
accomplished by studying, for example, the caspase-
2–dependent initiation of apoptosis, which seems to
“use” the mitochondria as an amplification route, and
the intricate pathways mediated by the activation of the
receptors for neurotrophins, which, when disrupted,
may abrogate the mechanisms of neuronal survival.
Furthermore, because damaged mitochondria can accu-
mulate in aging as a result of deficient autophagy (100),
it will be also important to identify the mechanisms
involved in autophagy in neurons committed to die in
various neurodegenerative disorders.
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